TRHC TABULA RASA HEALTHCARE

TRHC and Troy Medicare Leverage Technology to Provide Innovative Care Coordination

TRHC and Troy Medicare Leverage Technology to Provide Innovative Care Coordination

Partnership focuses on care and cost in health plans

MOORESTOWN, N.J. and CHARLOTTE, N.C., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. ("TRHC") (NASDAQ:TRHC), a leading provider of technology-enabled solutions to mitigate medication risk, reduce medical costs, and optimize client performance, today announced its health plan management group, PeakTPA, has signed an agreement to partner with Troy Medicare. is a licensed Medicare Advantage plan that empowers independent pharmacies to reduce health costs with data-enabled care coordination.

provides third party administrator (TPA) and “back office” services to healthcare organizations for optimized financial management and regulatory compliance. Services include claims adjudication, enrollment management, accounts receivable, and more.

“Because we are the first health plan to bridge the data silos between the pharmacy and the doctor’s office, we needed a technology partner that has experience in both arenas. We are proud to partner with Tabula Rasa HealthCare’s PeakTPA, which aligns perfectly with our vision to leverage technology to empower providers to deliver great care,” said Flaviu Simihaian, CEO of Troy Medicare.

Troy’s care coordination data and TRHC’s technology, services, and revenue model optimize client financial management and help fulfill regulatory requirements for health plan functions. The expertise in health plan management means health plan organizations can focus on delivering high-quality care to members.

“Tabula Rasa is pleased to be selected as Troy’s technology, care coordination, and adjudication partner,” said TRHC Chairman and CEO Calvin H. Knowlton, PhD. “Pharmacy in a health plan is a key component, providing dramatic results in terms of quality, patient safety, and cost-of-care. We look forward to delivering upon this synergy for Troy Medicare.”

About Tabula Rasa HealthCare

Tabula Rasa HealthCare is a leader in providing patient-specific, data-driven technology and solutions that enable health care organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower health care costs, and manage risk. TRHC provides solutions for a range of payers, providers, and other health care organizations. For more information, visit TRHC.com.

About Troy Medicare

Troy Medicare is a North Carolina-based Medicare Advantage plan (HMO) that uses data and technology to empower providers to truly impact each patient’s health and get rewarded for those results. The company is focused on the rural communities across the United States where pharmacists and physicians are the core of each member’s healthcare decisions. By reducing these providers’ administrative burden and empowering them with world-class data and technology, Troy Medicare has proven to meaningfully reduce health costs for members in each community.

Forward-Looking Statements

This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology.  Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions.  These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release.  Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC,  including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 1, 2019, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.

Contact

 

704-275-8900 Ext. 111

Dianne Semingson

 

T: 215-870-0829

Investors

Bob East or Asher Dewhurst

Westwicke Partners

 

T: (443) 213-0500

EN
10/09/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on TABULA RASA HEALTHCARE

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: July 27, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: July 25, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Tabula Rasa Healthcare Inc: 3 directors

A director at Tabula Rasa Healthcare Inc bought 2,000 shares at 5.630USD and the significance rating of the trade was 34/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch